Friday 6 November 2026
Export MEDP’s income statement to Excel — free account
Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
654.77
19.79
+3.12%
Follow MEDP
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
8 | 9 | 9 | 9 |
| 70.23% | 77.25% | 162.15% | 117.88% | ||
| 22.13% | 22.87% | 27.09% | 25.54% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(202.23%) | (663.29%) | (215.54%) | (680.52%) | |
Average Days of Receivables |
58.00 | 53.77 | 57.96 | 57.56 | |
Free Cash Flow per Share |
23.64 | 25.00 | 25.08 | 23.90 | |
Free Cash Flow |
681.87 | 711.00 | 706.69 | 667.63 | |
Capital Expenditures |
(31.36) | (28.18) | (45.97) | (55.42) | |
| Other line items | |||||
Cash ROIC |
71.32% | 56.83% | 75.46% | 51.74% | |
Accounts Receivable Turnover |
7.24 | 7.73 | 6.79 | 6.92 | |
Accounts Payable Turnover |
24.13 | 15.72 | 19.04 | 22.44 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
14.03 | 16.70 | 17.80 | 20.24 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.17) | (0.19) | (0.18) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.81% | 7.00% | 6.79% | 6.79% | |
Share Based Compensation of Revenue |
1.37% | 0.85% | 0.76% | 0.79% | |
Interest Coverage |
(41.86) | (49.23) | (38.03) | (31.66) | |
Operating CF/Net income |
1.58 | 1.61 | 1.53 | 1.40 | |
Depreciation/Fixed assets |
0.21 | 0.21 | 0.18 | 0.16 | |
Capex/Depreciation |
(1.11) | (1.00) | (1.65) | (2.03) | |
Revenue per Share |
87.72 | 94.16 | 98.75 | 101.59 | |
Operating CF per Share |
24.73 | 25.99 | 26.71 | 25.88 | |
Capex per Share |
(1.09) | (0.99) | (1.63) | (1.98) | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 2 Nov 2026